MEI Cash And Short Term Investments from 2010 to 2025

MEIP Stock  USD 2.43  0.03  1.22%   
MEI Pharma Cash And Short Term Investments yearly trend continues to be relatively stable with very little volatility. Cash And Short Term Investments are likely to grow to about 57.3 M this year. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2003-06-30
Previous Quarter
26.9 M
Current Value
23.7 M
Quarterly Volatility
49.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.
  
Check out the analysis of MEI Pharma Correlation against competitors.
To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

Latest MEI Pharma's Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of MEI Pharma over the last few years. Short Term Investments is an account in the current assets section of MEI Pharma balance sheet. This account contains MEI Pharma investments that will expire within one year. These investments include stocks and bonds that can be liquidated by MEI Pharma fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. MEI Pharma's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

MEI Cash And Short Term Investments Regression Statistics

Arithmetic Mean73,122,130
Geometric Mean53,823,231
Coefficient Of Variation71.14
Mean Deviation41,062,528
Median57,285,322
Standard Deviation52,015,545
Sample Variance2705.6T
Range176.4M
R-Value0.44
Mean Square Error2349.3T
R-Squared0.19
Significance0.09
Slope4,757,111
Total Sum of Squares40584.3T

MEI Cash And Short Term Investments History

202557.3 M
202444.1 M
202338.3 M
2022100.7 M
2021153.3 M
2020153.4 M
2019182.6 M

About MEI Pharma Financial Statements

MEI Pharma shareholders use historical fundamental indicators, such as Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash And Short Term Investments44.1 M57.3 M

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.